A vast number of factors are identified as the potential drivers of the market, such as technological advancements, rising incidences of accidents and injuries, improving regulatory framework, prevalence of organ failure, increasing government support in terms of initiatives and R&D expenditures, and growing prevalence of eye diseases.
Conversely, the factors such as the high cost associated with these devices are obstructing the growth of the market, acting as a major tailwind. Also, the risks associated with the collection techniques and contaminations are impeding the growth of the saliva collection devices and diagnostics market.
Various other factors such as the advancements in radiotracers, acceptance of nuclear imaging devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on diagnostic imaging centers are also expected to propel the growth of the market.
During various types of research conducted on gastric bypass, a drastic reduction (over 90 percent) in new onset type 2 diabetes was found. Also, in other obesity-related conditions assessed it was found that gastric bypass can bring a significant reduction in the occurrence of high blood pressure and dyslipidemia.
